A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
Phase 1
Recruiting
- Conditions
- OncologyMalignant Solid Tumor
- Interventions
- Drug: GEH200520 Injection / GEH200521 (18F) Injection - Part ADrug: GEH200520 Injection / GEH200521 (18F) Injection - Part BDiagnostic Test: Dynamic and Static - PET/CT scanDiagnostic Test: Static - PET/CT scan
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 50
- Registration Number
- NCT05629689
- Locations
- 🇳🇱
UMC Groningen, Groningen, Netherlands
Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- Drug: GE200486 0.5M Injection
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 15
- Registration Number
- NCT05569278
- Locations
- 🇳🇴
Rikshospitalet, Oslo, Norway
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
Phase 4
Active, not recruiting
- Conditions
- Metastatic Breast Cancer
- Interventions
- Drug: 18F Fluoroestradiol Radiopharmaceutical with PET/CT
- First Posted Date
- 2022-08-03
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 153
- Registration Number
- NCT05486182
- Locations
- 🇫🇷
CGFL, Dijon, France
🇫🇷CHU Grenoble Alpes, La Tronche, France
🇫🇷CHU de Limoges - Dupuytren, Limoges, France
GE CVUS Device Evaluation
Not Applicable
Completed
- Conditions
- Echocardiography
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 8
- Registration Number
- NCT05340244
- Locations
- 🇺🇸
The Children's Mercy Hospital, Kansas City, Missouri, United States
Dual Energy Cardiac CT Data Collection and Evaluation
Completed
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 30
- Registration Number
- NCT05171764
- Locations
- 🇨🇭
Zürich University Hospital, Zürich, Switzerland
Evaluation of a New Generation of PET-CT OMNI
Completed
- Conditions
- Oncology
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 45
- Registration Number
- NCT05154877
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, France
Demonstration Of A Next Generation PET CT System
Not Applicable
- Conditions
- Oncology
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2022-05-23
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 70
- Registration Number
- NCT05122715
- Locations
- 🇮🇱
Rambam Healthcare Campus, Haifa, Israel
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
Terminated
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2021-10-06
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 51
- Registration Number
- NCT05068726
- Locations
- 🇺🇸
Northern Arizona Healthcare, Flagstaff, Arizona, United States
🇺🇸TOI Clinical Research, Cerritos, California, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States
Feasibility Study Of Ambulatory Monitoring System
Not Applicable
Not yet recruiting
- Conditions
- Patient Monitoring
- First Posted Date
- 2021-07-13
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 300
- Registration Number
- NCT04959136
Evaluation of Continuous Non Invasive Blood Pressure With Adult Volunteers
Not Applicable
- Conditions
- Blood Pressure
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 12
- Registration Number
- NCT04876664